Assessing the association between GLP-1 receptor agonist use and diabetic retinopathy through the FDA adverse event reporting system
This information can help you and your provider evaluate whether supplementation addresses a genetic predisposition rather than guessing based on general recommendations
Recent cardiovascular outcome trials have demonstrated significant reductions in major adverse cardiovascular events in patients using these medications, making them valuable not just for weight loss but for overall cardiovascular health
Pairing GLP-1 therapy with the Precision Peptide Genetic Test ($99) gives you personalized insight into how your genetic makeup influences cholesterol metabolism, allowing your provider to optimize your treatment from day one
His prices are amazing, specials are offered quite often, and he never tries to oversell or push services for the sake of profit
CJC-1295 is used with or without DAC, depending on your needs